Abstract | AIMS: The interactions between cancer cells and platelets have been recognized to play an important role in cancer progress as well as metastasis, and interference with cancer-platelet interactions is an attractive strategy for cancer therapy. In the present study, two β-nitrostyrene derivatives: 3, 4-methylene-dioxy-β-nitrostyrene (MNS) and 4-O-benzoyl-3-methoxyl-β-nitrostyrene (BMNS) have been tested for their inhibitory effect on platelet activation caused by metastatic human breast cancer MDA-MB-231 and Hs578T cells. MAIN METHODS: KEY FINDINGS: MNS and BMNS prevented cancer cell-induced platelet aggregation, P-selectin expression, and PDGF secretion. Moreover, the β-nitrostyrenes reduced platelet adhesion to cancer cells, suggesting the initial cancer-platelet interactions are inhibited. In contrast to current antiplatelet strategies, the glycoprotein IIb/IIIa (GPIIb/IIIa) antagonist RGDS peptide only prevented cancer cells-induced platelet aggregation, but not platelet adhesion and secretion; whereas the cyclooxygenase inhibitor aspirin and the adenosine diphosphate ( ADP) scavenger apyrase affected neither platelet aggregation nor platelet secretion. SIGNIFICANCE: The inhibitory effects of the β-nitrostyrene derivatives on cancer-platelet interactions may offer a potential approach for repressing cancer metastasis.
|
Authors | Chien-Kei Wei, Fang-Rong Chang, Pei-Wen Hsieh, Chin-Chung Wu |
Journal | Life sciences
(Life Sci)
Vol. 143
Pg. 147-55
(Dec 15 2015)
ISSN: 1879-0631 [Electronic] Netherlands |
PMID | 26546721
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2015 Elsevier Inc. All rights reserved. |
Chemical References |
- Platelet Aggregation Inhibitors
- Styrenes
- beta-nitrostyrene
|
Topics |
- Blood Platelets
(drug effects, metabolism)
- Breast Neoplasms
(drug therapy, metabolism)
- Cell Adhesion
(drug effects, physiology)
- Cell Survival
(drug effects, physiology)
- Dose-Response Relationship, Drug
- Female
- Humans
- MCF-7 Cells
- Platelet Aggregation
(drug effects, physiology)
- Platelet Aggregation Inhibitors
(chemistry, pharmacology)
- Styrenes
(chemistry, pharmacology, therapeutic use)
|